HBM Partners was founded in 2001 with the goal to invest in private and public emerging biopharma and other healthcare-related companies. 

HBM Partners has a team of experienced professionals to source, analyse and engage in investments in biopharma, medical devices and diagnostics industries. HBM Partners has a track-record of over 100 investments that resulted so far in significant value creation by more than 60 trade sales and IPOs since inception.

HBM Partners is regulated by FINMA and advises SIX listed HBM Healthcare Investments and further specialised public and private equity investment products. 


Banking

HBM Partners

HBM Partners' headquarters in Zürich, Switzerland

Andreas Wicki

Matthias Fehr

Erwin Troxler

Didier De Montmollin

Francesco D'Amico

The Equity Team at HBM Partners is responsible for sourcing, analyzing, and managing investments in public and private healthcare-related companies, with a focus on biopharma, medical devices, and diagnostics. The team conducts in-depth market research, due diligence, and risk assessments to identify high-potential opportunities and create significant value through strategic investments. They also manage and optimize portfolio performance for specialized equity investment products and the SIX-listed HBM Healthcare Investments.

Equity Team

The Leadership Team at HBM Partners is responsible for setting the strategic direction and vision of the company, overseeing investment decisions in the biopharma and healthcare sectors, and ensuring operational excellence. Comprised of the CEO and CFOs, this team drives organizational growth, fosters relationships with stakeholders, and manages compliance with regulatory bodies like FINMA, ensuring the firm stays at the forefront of value creation in its investments.

HBM Partners

Org chart

Board & advisors

Teams

Equity Team

Leadership Team

Offices

HBM Partners

Org chart

Board & advisors

Teams

Equity Team

Leadership Team

Offices

Related companies